Do COVID-19 vaccines provide lasting protection?
Written by AI from saved sources. A script checks every quote and every figure against the saved sources, and a second AI compares each claim with its source. How we work and corrections
Yes, generally for several months, especially against severe illness, but protection fades. Vaccinated people can still catch COVID-19, and protection against infection generally fades sooner. The review's studies differed in vaccines, groups, results measured and how long people were tracked.
Checked against: WHO, CDC and the 30-study review, October 2026.
Why people believe it
Infections after vaccination and fading protection are real. A CDC survey asked 2,729 adults without a 2023–24 dose why they had not received it. Of these adults, 25.9% selected “the vaccine can't prevent infection” as a reason. People could choose several reasons. The authors warn that people's own reports and low survey response rates could skew the results.
“Vaccinated people still catch it”
Yes, but the US study below found added protection against infection with symptoms. A US study compared positive and negative tests in adults with symptoms. The adults were aged 18 or over and reported no condition weakening their immune systems. The updated 2023–24 XBB.1.5 dose added an estimated 54% protection against Omicron infection with symptoms. The comparison was with not receiving that dose. This estimate was at a median (middle value) of 52 days after vaccination. This early estimate covered only the first 119 days after vaccination.
A February 2025 study in CDC's MMWR found an estimated 33% added protection against COVID-19-related emergency department or urgent care visits in adults aged 18 or over, compared with not receiving a 2024–2025 dose. It covered 7–119 days after vaccination, so this estimate does not establish protection beyond that period.
“It wears off, so what's left?”
A 2026 review of 30 studies found generally modest, short-lived protection against infection across Omicron variants. Protection against severe illness generally lasted several months and faded more slowly. But some studies of vaccines updated for XBB.1.5 found much weaker or statistically uncertain protection against hospitalisation. Those findings concerned protection beyond six months after vaccination. The studies differed too much to combine into one percentage.
On its page updated in October 2026, CDC reports that the 2023–2024 vaccines added almost 70% protection against critical illness (intensive care admission or death) in adults aged 18 or over in the first two months, with protection decreasing over time. It reports about 50% added protection during the ten months after vaccination, an estimate covering that period rather than protection specifically at month ten.
The European Centre for Disease Prevention and Control's March 2025 review found some protection against long COVID in adults in the general population fully vaccinated before infection, compared with no vaccination. It could not draw firm conclusions for children, adolescents or people with weakened immune systems, or about shortening long COVID symptoms.
Denmark's 2025–26 programme gives a specific example. The estimates were for adults aged 65 or over who were offered seasonal vaccination. They covered 1 October 2025 to 31 January 2026. Estimated protection was 61% against COVID-related hospitalisation and 70% against COVID-related death. Protection against hospitalisation fell from 66% immediately after vaccination to 48% in the fourth month after vaccination. But the confidence intervals were wide. Within four months after vaccination, the report found no statistically significant decline in protection against COVID-related death. The report's overall estimates cover 1 October 2025 to 31 January 2026.
“Can I still pass it on?”
Vaccination does not guarantee that you cannot spread COVID-19. In an early-Omicron household study, “index patients” were the first household members to develop symptoms or test positive. Researchers compared contacts of index patients given a booster (extra vaccine dose) with contacts of unvaccinated index patients. The proportion of contacts with confirmed or probable COVID-19 was lower in the group whose index patients had received boosters. But vaccination, masking and isolating from others were likely closely linked within households. Researchers could not confirm that index patients spread the virus to household contacts. The researchers also could not confirm that all infected household contacts had the same variant.
Thinking tool: protection against what?
Before judging “it works”, ask what was measured, which groups were compared and over what period. In the US infection study, 54% meant estimated added protection against Omicron infection with symptoms. It was not a promise that 54% of recipients would never catch COVID-19. WHO defines effectiveness as how well vaccines work in the real world. It does not mean complete protection for every person. Use this tool on other claims by asking exactly what was measured before accepting the headline.
Official positions, with dates
WHO, 15 September 2026: recommends at least annual vaccination for its highest-risk groups, preferably two doses about six months apart. It does not routinely recommend repeat vaccination for healthy children and adolescents.
US CDC, 23 September 2026: recommends a 2026–27 dose for all adults aged 18 or over. Its September 2026 guidance recommends two 2026–2027 doses, normally six months apart, for adults aged 65 or over without weakened immune systems, including those vaccinated in earlier seasons. It calls giving more than one dose in this age group off-label use, meaning outside the approved use.
What people also ask
Is the COVID-19 vaccine lifetime?
Protection against severe COVID-19 generally lasts for several months but fades. WHO says protection against severe disease and death is highest in the first few months after vaccination. In its June 2026 report, the UK Health Security Agency estimated 17% added protection against hospitalisation at 35 weeks or more after a spring 2025 JN.1 booster in adults aged 75 or over in England. Protection had peaked at 54.5% at 5 to 9 weeks, but the late estimate was statistically uncertain.
How long does the COVID-19 vaccine remain effective?
The reviewed studies differed in vaccines, groups, results measured and how long people were tracked. WHO's May 2026 statement also reports limited tracking time and comparisons between vaccine versions when estimating added protection. How future variants may affect public health remains unknown.
Can you get COVID even if you have had the vaccine?
Yes. WHO calls an infection after vaccination a “breakthrough infection”. It says this does not mean the vaccine does not work.
What are the chances of getting COVID-19 after getting the vaccine?
The review did not combine the studies into one estimate of protection. Their methods, groups, vaccines and comparisons differed. Newer estimates commonly measure added protection above immunity (existing protection) from earlier vaccination or infection.
Check it yourself (5 minutes)
- Open WHO's COVID-19 vaccines Q&A.
- Find “How long does protection”.
- Read the first sentence: does WHO describe steady protection or a decline?
What you should have found
“Protection against severe disease and death is highest in the first few months after vaccination and then starts to decrease.”
Before you forward this: does the box at the top say exactly what the sources below say?
Check a claim like this yourself: is that health headline true? Check it in five moves.
Sources
- WHO, COVID-19 vaccines (2026).
- WHO, Vaccine efficacy, effectiveness and protection (2025).
- WHO, Statement on the antigen composition of COVID-19 vaccines (2026).
- CDC, Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024 (2024).
- BMC Infectious Diseases, Vaccine effectiveness across the Omicron evolutionary spectrum (BA.2, BA.5, XBB, JN.1, KP.3): a systematic review of studies published 2022–2025 (2026).
- European Centre for Disease Prevention and Control: Does COVID-19 vaccination reduce the risk and duration of post COVID-19 condition? (2025).
- Statens Serum Institut, Integrated surveillance of respiratory infections in 2025/26 – consolidated report (2026).
- UK Health Security Agency: Epidemiology of COVID-19 in England, July to December 2025 (2026).
- CDC, Reasons for non-vaccination with COVID-19, influenza, and RSV vaccines during the 2023–24 respiratory virus season (2024).
- CDC, SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 (2022).
- CDC, Overview of COVID-19 Vaccines and Vaccination (2026).
Updates: CDC, 2026-2027 COVID-19 Vaccination Guidance for People Who Are Not Immunocompromised (2026); CDC, Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 (2025); CDC, Benefits of Getting Vaccinated (2026).